PCBL PCBL Chemical Q3 FY25 results (Oct–Dec 2024) and concall
PCBL Chemical delivered a steady performance in Q3 FY25, characterized by robust volume growth in Carbon Black and the integration of Aquapharm Chemicals. Despite macro headwinds like destocking in Western markets and crude-linked realization drops, the company maintained high capacity utilization and expanded its specialty footprint. Management is aggressively pursuing a 1-million-ton capacity target through new greenfield projects in Andhra Pradesh and brownfield expansions in Tamil Nadu.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 2,163 | 2,010 |
| EBITDA | 364 | 317 |
| Net profit | 123 | 93 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
